Bulgaria - bulgarsk - БАБХ (Българска агенция по безопасност на храните)

vetoquinol s.a. - Фебантел, Пирантел, Празиквантел - таблетки - 150 mg/таблетки, 50 mg/таблетки, 50 mg/таблетки - кучета

Bulgaria - bulgarsk - БАБХ (Българска агенция по безопасност на храните)

bayer animal health gmbh - Фебантел, Пирантел эмбоната, Празиквантел - таблетки - 150 mg/таблетка; 144 mg/таблетка; 50 mg/таблетка - кучета

Bulgaria - bulgarsk - БАБХ (Българска агенция по безопасност на храните)

chanelle pharmaceutical manufacturing limited - Празиквантел, Пирантел, Фебантел - таблетка - 175 mg/таблетка, 175 mg/таблетка, 525 mg/таблетка - кучета

Den europeiske union - bulgarsk - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - тиотепа - hematopoietic stem cell transplantation; neoplasms - Антинеопластични средства - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Bulgaria - bulgarsk - БАБХ (Българска агенция по безопасност на храните)

chanelle pharmaceuticals manufacturing ltd. - Мильбемицин оксим, Празиквантел - таблетка - 12.5 mg/ml; 125 mg/ml - кучета

Den europeiske union - bulgarsk - EMA (European Medicines Agency)

deciphera pharmaceuticals (netherlands) b.v. - ripretinib - Стомашно-чревни стромални тумори - Антинеопластични средства - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.

Den europeiske union - bulgarsk - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - nivolumab - Карцином, недребноклетъчен белодроб - Антинеопластические и имунномодулиращи агенти, моноклонални антитела - nivolumab bms е показан за лечение на локално напреднал или метастазирал сквамозен недребноклетъчен рак на белия дроб (nsclc) след предшестваща химиотерапия при възрастни.

Den europeiske union - bulgarsk - EMA (European Medicines Agency)

fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - Всички други терапевтични продукти - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.

Den europeiske union - bulgarsk - EMA (European Medicines Agency)

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - анти-туморни агенти - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.

Bulgaria - bulgarsk - БАБХ (Българска агенция по безопасност на храните)

eurovet animal health bv - pimobendan - таблетка - 10 mg/таблетка - кучета